Corporate venture capital deals can offer startups significant advantages, including capital, market access, and strategic credibility from an established industry player. However, founders and executives who focus only on valuation and ownership
More
The United States Citizenship and Immigration Services issued updated guidance on 5 August 2026, reshaping how immigration petitions and applications are reviewed and adjudicated. The new policy has quickly made itself felt
More
Legal professionals are adopting AI at speed, but few can explain why they are using the models they chose or what those models actually cost per query. Firms are competing to showcase
More
Justice Clarence Thomas rarely grants media interviews, making his appearance on Ted Cruz’s podcast a notable and carefully timed event this week. Thomas sat down for a conversation on “Verdict with Ted
More
London’s FTSE 100 closed higher on Tuesday, lifted by a sharp drop in oil prices and growing investor anticipation ahead of Nvidia’s closely watched earnings report. The FTSE 100 Index ended the
More
Wall Street rebounded strongly as technology stocks led a broad market recovery, with investors closely watching upcoming results from chipmaker Nvidia. Markets showed renewed appetite for risk assets as traders positioned themselves
More
China’s major banks are caught between two competing pressures as Washington ramps up its financial campaign against Tehran and those who support it. U.S. Treasury Secretary Scott Bessent warned this week that
More
Kainos, Northern Ireland’s only FTSE 250 listed company, is pressing ahead with a significant recruitment drive, advertising 340 new roles across its operations. The Belfast-based technology firm has made clear its position
More
In the heart of the Square Mile, a handful of institutions survive as living relics of a London that has otherwise been swept away by centuries of transformation. Sweetings, located in the
More
Johnson & Johnson has secured a significant regulatory win, with the FDA approving its therapy Imaavy for a second indication targeting a rare and life-threatening blood condition. The approval covers Imaavy, known
More